David Tatarakis

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Denali Therapeutics (United States)36.1%
• University of Massachusetts Chan Medical School6.8%
• Amsterdam Neuroscience6%
• German Center for Neurodegenerative Diseases5.3%
• Ludwig-Maximilians-Universität München5.1%
• Biogen (United States)4.8%
• Other36%

Fields

• Neuroscience35.8%
• Medicine27%
• Biochemistry, Genetics and Molecular Biology25.1%
• Immunology and Microbiology7.4%
• Materials Science1.9%
• Engineering0.9%
• Other1.9%

Topics

• Neuroinflammation and Neurodegeneration Mechanisms26.3%
• Alzheimer's disease research and treatments18.7%
• Inflammation biomarkers and pathways8.4%
• RNA Interference and Gene Delivery8.1%
• Tryptophan and brain disorders6%
• Neurological Disease Mechanisms and Treatments5.1%
• Other27.4%